Literature DB >> 8738362

The role of adjuvant radiation and multiple resection within the surgical management of brain metastases.

F Weber1, A Riedel, W Köning, J Menzel.   

Abstract

Cerebral metastases occur in 25% to 35% of all cancer patients. The advances in systemic and topical treatment as well as the rising incidence of lung cancer and melanomas are associated with an increasing incidence of cerebral metastases. More than 20,000 patients die every year in the Federal Republic of Germany of this disease. This retrospective analysis covers 145 patients who underwent surgery. Survival analysis of different subgroups was performed. The patients were grouped according to their clinical status and the different therapeutical procedures which were performed. Group A, consisting of all those patients where a gross total resection could be performed and where no systemic disease was apparent at the time of craniotomy showed the best results, having the highest portion of long term survivors. Group B, consisting of those patients who underwent a subtotal resection and who had no systemic disease at the time of craniotomy, had a worse outcome. Group C patients (gross total resection and systemic disease) as well as Group D (subtotal resection and systemic disease) presented the poorest results with respect to survival. A benefit was mediated by adjuvant radiation as well as multiple resections. Surgery is the method of choice for the treatment of a single metastasis. Advances in microsurgery nowadays sometimes justify even the removal of multiple metastases, depending on their location, on the general condition of the patient and on prognosis.

Entities:  

Mesh:

Year:  1996        PMID: 8738362     DOI: 10.1007/bf00346606

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  43 in total

1.  Results and prognostic factors of surgery in the management of non-small cell lung cancer with solitary brain metastasis.

Authors:  P Macchiarini; R Buonaguidi; M Hardin; A Mussi; C A Angeletti
Journal:  Cancer       Date:  1991-07-15       Impact factor: 6.860

2.  Dynamic stereotactic radiosurgery in the palliative treatment of cerebral metastatic tumors.

Authors:  J L Caron; L Souhami; E B Podgorsak
Journal:  J Neurooncol       Date:  1992-02       Impact factor: 4.130

3.  Palliative surgery for brain metastases of malignant melanoma.

Authors:  S Oredsson; C Ingvar; L G Strömblad; P E Jönsson
Journal:  Eur J Surg Oncol       Date:  1990-10       Impact factor: 4.424

4.  Resection for solitary brain metastasis. Role of adjuvant radiation and prognostic variables in 229 patients.

Authors:  S R Smalley; E R Laws; J R O'Fallon; E G Shaw; M F Schray
Journal:  J Neurosurg       Date:  1992-10       Impact factor: 5.115

5.  Stereotactic radiosurgery using a linear accelerator.

Authors:  Y Kyuma; A Hayashi; T Kitamura; K Yamashita; H Muranishi; M Hioki
Journal:  Neurol Med Chir (Tokyo)       Date:  1992-07       Impact factor: 1.742

6.  Radiosurgical treatment of cerebral metastases. Method, indications and results.

Authors:  V Sturm; B Kimmig; R Engenhardt; W Schlegel; O Pastyr; H Treuer; S Schabbert; J Voges
Journal:  Stereotact Funct Neurosurg       Date:  1991       Impact factor: 1.875

7.  Defining the role of radiosurgery in the management of brain metastases.

Authors:  M P Mehta; J M Rozental; A B Levin; T R Mackie; S S Kubsad; M A Gehring; T J Kinsella
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

8.  Late survival of non-small cell lung cancer patients with brain metastases. Influence of treatment.

Authors:  D B Chang; P C Yang; K T Luh; S H Kuo; R L Hong; L N Lee
Journal:  Chest       Date:  1992-05       Impact factor: 9.410

9.  Linear accelerator and Greitz-Bergstrom's head fixation system in radiosurgery of single cerebral metastases. A report of 86 cases.

Authors:  V Valentino; M A Mirri; G Schinaia; G Dalle Ore
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

10.  Single brain metastases from kidney tumors. Clinico-pathologic considerations on a series of 29 cases.

Authors:  M Salvati; M Scarpinati; E R Orlando; P Celli; F M Gagliardi
Journal:  Tumori       Date:  1992-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.